Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Operations

v2.4.0.6
Consolidated Statements Of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended 66 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Operating expenses:        
Research and development $ 8,583 $ 8,341 $ 2,270 $ 24,542
General and administrative 5,755 900 343 7,614
In-process research and development 20,706     20,706
Loss from operations (35,044) (9,241) (2,613) (52,862)
Interest income 165 61   244
Interest expense (74) (1,535) (1,053) (3,282)
Other income   733   733
Warrant expense (1,407)     (1,407)
Net loss (36,360) (9,982) (3,666) (56,574)
Common Stock dividend to Series A Convertible Preferred Stockholders (5,861)     (5,861)
Net loss attributed to Common Stockholders $ (42,221) $ (9,982) $ (3,666) $ (62,435)
Basic and diluted net loss per common share $ (5.51) $ (2.24) $ (1.01)  
Weighted average common shares outstanding-basic and diluted 7,662,984 4,453,786 3,612,769